Dr. David Barzilai notes retatrutide 12 mg had triple Ozempic's dropout rate
He points out 7.9% quit the 12 mg dose over side effects versus 2.7% on Ozempic, a 5.2 point gap, and flags more skin sensation complaints.
Recap by typeshit. Post by Agingdoc🩺Dr David Barzilai🔔MD PhD MS MBA DipABLM on X.